Non-invasive prenatal testing at early stage of pregnancy
US11946104B2 · kind B2 · utility
0Cited by
3References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 7, 2020 |
| Grant date | Apr 2, 2024 |
| Priority date | — |
| Expiry date | Jul 7, 2040 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/387
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
A highly accurate non-invasive prenatal testing methodology that allows accurate fetal rhesus determination and fetal DNA fraction measurement in a single assay is provided. The disclosed testing may be administered as early as at week 10 of pregnancy and can be conveniently combined with prenatal genetic disease testing and detection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.